肠道菌群与急性心肌梗死的相关性研究  

Study on the relationship between intestinal flora and acute myocardial infarction

作　　者：李晓红[1] 王鹏飞[1] 吴广 赵兴胜 Li Xiaohong;Wang Pengfei;Wu Guang;Zhao Xingsheng(Clinical Medical College,Baotou Medical College,Inner Mongolia University of Science and Technology,Hohhot 010000,China;Department of Cardiology,Inner Mongolia People’s Hospital,Hohhot 010017,China)

机构地区：[1]内蒙古科技大学包头医学院内蒙古临床医学院,呼和浩特010000 [2]内蒙古自治区人民医院心脏中心,呼和浩特010000

出　　处：《中国心血管杂志》2021年第4期385-389,共5页Chinese Journal of Cardiovascular Medicine

基　　金：国家自然科学基金(81860088)。

摘　　要：急性心肌梗死(AMI)作为致死率较高的心血管疾病(CVD)之一,其发病率仍居高不下。近年来,大量研究发现肠道菌群作为"第二基因组"参与CVD的发病。本文将就肠道菌群及其代谢产物与AMI的关系、可能机制作一综述,以期为AMI的治疗提供新思路。Acute myocardial infarction(AMI) is one of the most fatal cardiovascular diseases(CVD), and the incidence is still high. In recent years, a large number of studies have found that intestinal flora act as the "second genome" and may involve in the pathogenesis of CVD. This article will review the relationship between intestinal flora, its metabolites and AMI and possible mechanism, in order to provide new ideas for the treatment of AMI.

关 键 词：肠道菌群 微生物区系 急性心肌梗死 代谢产物 

分 类 号：R542.22[医药卫生—心血管疾病]